#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oropharyngeal squamous cell carcinoma Metachromatic leukodystrophy Systemic lupus erythematosus Spinal cord injury Biliary cancer metastatic Gastrointestinal stromal tumour Malignant glioma Hereditary hypophosphataemic rickets Ovarian cancer stage III Adrenogenital syndrome Pancreatic neuroendocrine tumour Haemophilia B with anti factor IX Transient ischaemic attack Neuroendocrine tumour of the lung Alpha-1 antitrypsin deficiency More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid – Trials in Disease Optic glioma – Trials in Disease Focal segmental glomerulosclerosis – Diagnostics Leiomyosarcoma recurrent Acute respiratory distress syndrome – Diagnostics Encephalitis autoimmune – Treatment Stevens-Johnson syndrome – Trials in Disease Leiomyosarcoma metastatic – Treatment Hereditary optic atrophy – Life with Disease Lymphangioma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fluoroestradiol F-18 Lenograstim Tralokinumab Isatuximab PEGZILARGINASE Vinblastine Sulfate Ponatinib Sildenafil Nirogacestat Hydrobromide GSKVX000000034796 Cd7-Cart01 Patritumab Deruxtecan Mps-213 Diacerein Regn7508 Piperacillin Monohydrate Amiloride Hydrochloride Interferon Gamma Sabestomig Serine More therapies…

    Learn about Your Condition

    Pneumonia chlamydial Essential hypertension Dyskinesia Chondrosarcoma metastatic CADASIL Hereditary ataxia Hepatitis D Decreased appetite Synovial sarcoma Perineal injury Breast neoplasm Nephrogenic anaemia Acquired haemophilia Infection Pouchitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Evaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Germany The Netherlands Poland Spain

  • Study of D-cycloserine with theta-burst brain stimulation for adults with major depressive disorder

    Recruiting

    2 1
    Investigated Diseases:
    • Major depression
    Sweden

  • Study of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    • Myelodysplastic syndrome
    • Neoplasm
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    • Ruxolitinib
    • Venetoclax
    France Italy Poland Spain

  • Study of brimonidine tartrate gel to prevent nerve damage in breast cancer patients receiving taxane treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuropathy peripheral
    Investigated Drugs:
    • Brimonidine Tartrate
    France

  • Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • GSK5764227
    • Topotecan
    Bulgaria Finland France Germany Greece Hungary +7

  • Study of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures

    Recruiting

    3 1 1
    Investigated Diseases:
    • Generalised tonic-clonic seizure
    • Partial seizures
    Investigated Drugs:
    • Prax-628
    • VORMATRIGINE
    Germany Italy Poland Spain
Previous Page
1 … 126 127 128 129 130 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!